Anand Rathi Share & Stock Brokers, EPack Prefab and Gujarat Kidney gets Sebi nod for IPO

Anand Rathi Share and Stock Brokers, Epack Prefab Technologies and Gujarat Kidney and Super Speciality, has received final observation from the capital markets regulator, Securities and Exchange Board of India (SEBI) for IPO.

Anand Rathi Share and Stock Brokers IPO

Anand Rathi Group’s Brokerage Arm, Anand Rathi Share and Stock Brokers has refiled its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) for its Rs 745 crore Initial Public Offering (IPO). Previously, the company had filed its DRHP in the month of December 2024. The IPO with a face value of Rs 5 is entirely a fresh issue of shares up to Rs 745 crore.

Anand Rathi Share and Stock Brokers Limited provides a wide range of financial services, including broking, margin trading, and distribution of financial products, under the brand name ‘Anand Rathi.’ Catering to a diverse clientele, the company serves retail investors, high-net-worth individuals (HNIs), ultra-HNIs, and institutional clients.

EPack Prefab Technologies IPO

Noida-based EPack Prefab Technologies has filed its Draft Red Herring Prospectus (DRHP) with the capital markets regulator, the Securities and Exchange Board of India (SEBI) to raise funds through an Initial Public Offering (IPO). The IPO, with a face value of Rs 2, consists of fresh issues of shares up to Rs 300 crore and an offer-for-sale of up to 10 million equity shares by Promoter Group and Selling Shareholders.

 

Incorporated in 1999, EPack Prefab Technologies has a legacy spanning over 25 years and operates across two distinct business verticals, Pre-Fab Business and EPS Packaging Business. The company sells its products under the brand names ‘EPACK PREFAB’ for its Pre-Fab Business and ‘EPACK PACKAGING’ for its EPS Packaging Business. It has received a Certificate of Excellence from the Golden Book of World Records for achieving the “fastest erection of a pre-engineered factory building” at Mambattu, Andhra Pradesh.

 

Gujarat Kidney and Super Speciality IPO

Gujarat Kidney and Super Speciality Limited had filed its Draft Red Herring Prospectus (DRHP) with capital markets regulator, Securities and Exchange Board of India (SEBI) to raise fund through Initial Public Offering (IPO). The IPO, with a face value of Rs 2, is a fresh issue of shares up to 2.2 crore Equity Shares.

Gujarat Kidney and Super Speciality is one of the regional healthcare companies located in the central region of state of Gujarat and operates a chain of mid-sized multispeciality hospitals, providing integrated healthcare services, with a focus on secondary and tertiary care. As of March 20, 2025, on a consolidated basis, it operates six (06) multispeciality hospitals and (03) pharmacies operating within our Hospitals, Gujarat Kidney and Superspeciality Hospital (Vadodara), Gujarat Multispeciality Hospital (Godhra), Raj Palmland Hospital Private Limited (Bharuch), M/s. Surya Hospital and ICU (Borsad), Gujarat Surgical Hospital (Vadodara), Ashwini Medical Centre (Anand) and Ashwini Medical Store (Anand) with a total bed capacity of 400 beds, approved bed capacity of 355 beds and operational bed capacity of 250 beds.